Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × monalizumab × Thoracic × Clear all

Phase

Status

Recruiting 2 Completed 2 Active not recruiting 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Cisplatin 5 durvalumab 3 Etoposide 3 Docetaxel 3 Carboplatin 3 Specimen Handling 2 pembrolizumab 1 osimertinib 1 monalizumab 1 icotinib 1 famitinib 1 decitabine and cedazuridine drug combination 1 dabrafenib 1 ceralasertib 1 cemiplimab 1 alirocumab 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiosurgery 1 Radionuclide Imaging 1 Radiation 1 Prednisone 1 Positron-Emission Tomography 1 Platinum 1 Pemetrexed 1 Panitumumab 1 Paclitaxel 1 Nivolumab 1 Monatide (IMS 3015) 1 Methods 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05903092 2026-03-12

MOZART

Hoosier Cancer Research Network

Phase 2 Suspended

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡